Goldman Sachs’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.9M | Sell |
344,972
-288,138
| -46% | -$24.1M | ﹤0.01% | 1512 |
|
|
2025
Q1 | $45.2M | Buy |
633,110
+213,667
| +51% | +$15.3M | 0.01% | 1121 |
|
|
2024
Q4 | $18.9M | Buy |
419,443
+56,293
| +16% | +$2.53M | ﹤0.01% | 1829 |
|
|
2024
Q3 | $18.3M | Buy |
363,150
+162,112
| +81% | +$8.19M | ﹤0.01% | 1801 |
|
|
2024
Q2 | $8.2M | Sell |
201,038
-10,879
| -5% | -$444K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $9.07M | Buy |
211,917
+143,318
| +209% | +$6.13M | ﹤0.01% | 2124 |
|
|
2023
Q4 | $2.76M | Buy |
+68,599
| New | +$2.76M | ﹤0.01% | 3002 |
|
|
2021
Q3 | – | Sell |
-7,292
| Closed | -$124K | – | 5516 |
|
|
2021
Q2 | $124K | Buy |
7,292
+3,354
| +85% | +$57K | ﹤0.01% | 5066 |
|
|
2021
Q1 | $74K | Sell |
3,938
-867
| -18% | -$16.3K | ﹤0.01% | 5086 |
|
|
2020
Q4 | $139K | Sell |
4,805
-15,145
| -76% | -$438K | ﹤0.01% | 4395 |
|
|
2020
Q3 | $751K | Buy |
+19,950
| New | +$751K | ﹤0.01% | 3467 |
|
|
2020
Q2 | – | Sell |
-2,622
| Closed | -$94K | – | 4536 |
|
|
2020
Q1 | $94K | Buy |
+2,622
| New | +$94K | ﹤0.01% | 4178 |
|
|
2017
Q4 | – | Sell |
-136
| Closed | -$5K | – | 4281 |
|
|
2017
Q3 | $5K | Sell |
136
-250
| -65% | -$9.19K | ﹤0.01% | 4241 |
|
|
2017
Q2 | $15K | Hold |
386
| – | – | ﹤0.01% | 4350 |
|
|
2017
Q1 | $21K | Buy |
386
+66
| +21% | +$3.59K | ﹤0.01% | 4320 |
|
|
2016
Q4 | $19K | Sell |
320
-31
| -9% | -$1.84K | ﹤0.01% | 4358 |
|
|
2016
Q3 | $24K | Buy |
+351
| New | +$24K | ﹤0.01% | 4419 |
|